ARTICLE | Company News

Insight Genetics, Vanderbilt-Ingram Cancer Center deal

September 20, 2010 7:00 AM UTC

Insight Genetics and Vanderbilt-Ingram Cancer Center partnered to identify genetic markers to help select targeted therapeutics effective for triple-negative breast cancer patients. The partners will use research from VICC that used an algorithm to identify up to six subtypes of triple-negative breast cancer. ...